Trospium chloride once-daily extended release is effective and well tolerated for the treatment of overactive bladder syndrome: an integrated analysis of two randomised, phase III trials.

Trospium chloride once-daily extended release is effective and well tolerated for the treatment of overactive bladder syndrome: an integrated analysis of two randomised, phase III trials. Int J Clin Pract. 2009 Dec; 63(12):1715-23.

View in: PubMed

subject areas

Benzilates
Delayed-Action Preparations
Double-Blind Method
Drug Administration Schedule
Female
Humans
Male
Middle Aged
Muscarinic Antagonists
Nortropanes
Treatment Outcome
Urinary Bladder, Overactive

authors with profiles

Peter Sand